ONE HEALTH - Action Track 3

Controlling and eliminating endemic zoonotic, neglected tropical and vector borne diseases

One Health

ONE HEALTH: A Comprehensive Approach for Addressing Health Threats at the Human-Animal-Environment Interface

Action track 3, “Controlling and eliminating endemic zoonotic, neglected tropical and vector-borne diseases,” focuses on the prevention, surveillance, control, and elimination of Neglected Infectious Diseases (NIDs). Since most of NIDs are zoonotic diseases, to tackle them, it is essential to promote the intersectoral coordination and integration of strategies and interventions within the human-animal-environmental interface, in line with the One Health approach, and ensuring efficiency, effectiveness and sustainability.

PAHO promotes the coordination and integration of strategies aimed at humans (diagnosis and early and adequate treatment), and vectors, including management of the environment to reduce its proliferation and interventions among animal reservoirs. Therefore, there are promoted and applied intersectoral and integrated actions to address all aspects of the neglected zoonotic tropical diseases (NTZD) in the endemic countries, which implies working on national and regional policies.

Directed technical cooperation and country experiences

Virtual trainings

Good practices

  • Promote the conformation of National Zoonosis committees, and periodic meetings where recent NTZD epidemiological situation can be shared and coordinated actions can be defined accordingly as to tackle NTZD.
  • Support the coordination at national, subnational, and local levels, of national health professionals of different sectors (human, animal, and environmental) to define a coordinate response to NTDs.
  • Development of technical documents and operational guidelines to tackle diseases with One Health approach which includes strategies towards the environment, vector control and animal reservoirs.
  • Support the access to treatment products for the affected populations:
    • Since 2022, a five-year agreement was signed between WHO and the pharmaceutical company Bayer for the donation of treatment of people exposed to or infected by the pork tapeworm Taenia solium. PAHO has worked in close collaboration with WHO to obtain data and interest from the countries to reinforce the agreement.
    • An innovative treatment option based on the combination of dimeticones has been made available to Member States through the PAHO Strategic Fund to treat tungiasis.

Guidelines, norms, relevant publications and support documents

Fecha